Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective observational long-term safety and functional status study in rheumatoid arthritis patients previously enrolled in CP-690,550 studies
2006-006373-25Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tofacitinib in rheumatoid arthritis (RA), sponsored by Pfizer. Primary endpoint: Confirmed lymphoproliferative disorder episodes. Started Jan 2007; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-006373-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006373-25.